Shantivijay Jewels completes scheme of amalgamation

Shantivijay Jewels Ltd has informed BSE that the amalgamation of Shantivijay Alloy Castings Private Ltd being a wholly owned subsidiary company of Shantivijay Jewels Ltd with the company has been completed and operational on March 26, 2002 upon filing of the orders passed by the Bombay High Court sanctioning the relevant scheme with the Registrar of Companies, Maharashtra on the said date and the relevant scheme of Amalgamation has become effective from April 1, 2001 (Appointed date). No equity shares would be required to be issued by the company as the transferor company is wholly owned subsidiary of the company.

State Bank of Bikaner & Jaipur announces change in management structure

State Bank of Bikaner & Jaipur has informed BSE about that S D S Minhas has taken over as director of the bank wef March 20, 2002 in place of V P Grover who has since ceased to be a director of the bank wef March 20, 2002.

BSEL Information Systems announces change in management structure

BSEL Information Systems Ltd has informed BSE about the following changes in the Board of Directors of the company wef March 05, 2002 Kartik D Sheth resigned as the Managing Director, continues as a Director Hitesh D Vora resigned as a Whole-Time Director, continues as a Director Kirit R Kanakiya appointed as a Whole-Time Director

Mukat Pipes director resigns

Mukat Pipes Ltd has informed BSE that Harinder Singh Ahluwalia, director of the company has resigned from March 15, 2002.

Times Guaranty appoints additional director

Times Guaranty Ltd has appointed Avinash Jain as additional director on the board of the company.

IDBI withdraws nominee director from Mangalore Chem

Industrial Development Bank of India has withdrawn the nomination of S Gajendran, Chief General Manager, IDBI Chennai with effect from March 27, 2002 as Director of Mangalore Chemicals & Fertilizers Ltd.

Philips India phasing out operations at ETG group factory

Philips India Ltd has informed BSE that the company introduced a Voluntary Retirement Scheme in the company's Enabling Technology Group factory at Kolkata on March 8. In response thereof all the workers have opted for the said Voluntary Retirement Scheme and have been released on March 30, 2002. In view of the above development, the company is phasing out manufacturing operations at the factory.

TV 18 Board approves allotment of equity shares on preferential basis

At the meeting of the Board of Directors of Television Eighteen India Ltd held on April 1, 2002 the following matters were decided: 1. Allotment of 7,00,000 equity shares of Rs 10 each issued at a premium of Rs 78 per share aggregating to Rs 88 per share as preferential allotment pursuant to the approval of the Board meeting dated December 07, 2001 and the EGM dated January 2, 2002. 2. Issue of Secured Partly Convertible Debentures of Rs 150 each, to be issued to the existing shareholders on Rights basis in the ratio of one SPCD for every 13 equity shares held. The detailed terms and conditions will be worked out in consultation with the Lead Managers to the Rights issue.

TV 18 to retain its 49% equity stake in CNBC India

Television Eighteen India Ltd has informed BSE that it planned to retain its 49% equity stake in CNBC India. Under the revised arrangement, TV 18 will not divest its 20% equity stake in CNBC India in favour of Sony Entertainment Television. The Company had earlier given SET the option to purchase 20% equity stake in CNBC India that would be divested from the 49% owned by TV 18. Thus an increased proportion of the benefit of value created by the CNBC India channel will continue to accrue to the shareholders of TV 18 As a part of the modified working arrangement TV 18 will manage the sales of advertisement time (free commercial time) of the CNBC India business news channel. The Company has set up the initial marketing infrastructure, which is being further strengthened for this purpose. TV 18 also has a distribution alliance with SET for CNBC India effective until March 2003, which will continue in its present form Both TV 18 and SET will continue to work closely and new arrangement would help maximize the synergies between the CNBC India channel and the SET channel bouquet, further building on the strong foundation established between the two companies over the last few years.

Geometric Software in negotiation with a software arm of an automobile major in Japan for undertaking project development activity

Geometric Software Solutions Company Ltd has informed BSE that the company is in advanced negotiation with a software arm of an automobile major in Japan for undertaking project development activity around the CATIA V5 environment. In the event the company receives the order, it will be in a form of pilot project, which will have little material impact in the short term. Providing it successfully completes this pilot project, the company is expected to receive additional orders, which are likely to have a material impact in the long term.

Bharat Electronics announces provisional results for the year 2001-02

Bharat Electronics Ltd has achieved sales of Rs 19391 million during the year 2001-2002 as against Rs 17153.30 million last year (an increase of 13%) and an estimated profit before tax of Rs 2832.70 million for the year 2001-2002 as against Rs 2199.10 million last year (an increase of 28.80%).

IT&T Board authorises management to give effect to transfer of Technology Services division

At the Board meeting of IT&T Ltd held on Monday, the board has authorised Rohitasava Chand, Executive Chairman, Karan Puri Managing Director & Hemant Kohli, Director & CEO of the company severally to give effect to the resolution pertaining to the transfer of its technology services (Smartsourceit) division of the company to the wholly owned subsidiary of the company- IT&T Net-Managed Services Ltd & to do all such acts, matters and things as may be deemed necessary and/or expedient in the interests of the company and in accordance with the laws of the land.

Ashok Leyland approves appointment of directors

At the meeting of the board of directors of Ashok Leyland Ltd held on March 27, 2002 the following appointments relating to directors were approved: 1. R Jagannath, Deputy Managing Director whose term would expire on March 31, 2002 has been re-appointed as Deputy Managing Director for a period of one year upto March 21, 2003. 2. D Balaji Rao whose nomination has been withdrawn by ICICI, has been appointed as an Independent Director.

HLL to seek shareholders approval for transferring its Diversey Lever business

Hindustan Lever Ltd has informed BSE that the Company will be seeking the consent of the shareholders for transfer of its Diversey Lever business to Johnson Wax Professional Pvt Ltd by a postal ballot to be submitted to the scrutinizer on or before May 2, 2002.The results of postal ballot will be announced on May 8, 2002.

Jain Irrigation Systems announces change in management structure

Jain Irrigation Systems Ltd has informed BSE that the Board of Directors have accepted the resignations of A S Ajgaonkar, Director- Corporate Affairs & J J Kulkarni Director - Product Development as Director(s) of the Company. The Board has also decided to keep casual vacancies created, vacant for the time being. Dr P V Sane has also expressed his inability to attend the meetings for a period of 6 months as he is travelling out of India from April 3, 2002. He, therefore, has appointed A S Ajgaonkar as an alternate to him to vote and to attend meetings of Board etc. in the next 6 months.

Amforge Industries announces change in management structure

Amforge Industries Ltd has announced the following changes in the management structure of the company: 1. Yogiraj Markar has resigned as Chairman & Managing Director of the company by reason of old age, with effect from March 31, 2002. He will continue as part-time Director 2. Sanjeev Kumar has resigned from the Executive Directorship of the company with effect from March 28, 2002 by reason of his pre-occupation. Henceforward, he will remian as prt-time Director of the company. 3. Puneet Makar has been appointed as Chairman & Managing Director of the company wef April 1, 2002 4. B L Gupta has been appointed as Additional Director of the company with effect from March 28, 2002.

Amforge Industries enters into agreement for sale of assets relating to Wheels Mfg

Amforge Industries Ltd has informed BSE that the company has entered into an agreement with M/s Wheels India Ltd, Chennai for sale of its plant & machinery situated at Faridabad, exclusively relating to Wheels Manufacturing process, at a consideration of Rs 108.20 million on March 30, 2002.

Navin Tayal resigns from the directorship of Bank of Rajasthan

Bank of Rajasthan Ltd has informed BSE that Navin Kumar Tayal has resigned from the directorship of the bank and his resignation has been accepted by the board of directors in their meeting held on March 26, 2002 with immediate effect.

Deepak Bhagchandaney appointed as Additional & Wholetime Director of Spanco Telesystem

Spanco Telesystems & Solutions Ltd has informed BSE that the Board of Directors have appointed Deepak L Bhagchandaney as Additional and Wholetime Director of the Company with effect from March 15, 2002

Khoday India announces change in management structure

Khoday India Ltd has informed BSE that the following Directors have resigned from the board of directors of the Company with effect from March 30, 2002: K R Nithyanand----Wholetime Director K H Gurunath----Wholetime Director K H Srinivas----Director K P Ghanshyam----Director K S Giridhar----Director

Wockhardt receives nod from DCGI for Human Clinical trial for its proprietary new anti-infective WCK-771

Wockhardt Ltd has received approval from the Drugs Controller of India (DCGI) for going ahead with Human Clinical trial (Phase-1) for its new anti-infective drug WCK-771. In November 2001, Wockhardt earned the distinction of being the first Indian pharmaceutical company to file an Investigational New Drug application with the DCGI for its NEW Chemical Entity (NCE) WCK-771, in the anti-infective segment. Wockhardt's proprietary compound WCK-771 is now eligible for Phase-1 Human Clinical trial after successfully undergoing pre-clinical experimental trial (animal studies). Phase-1 clinical trial involves administration of the drug in healthy male volunteers. DCGI approved WCK-771 after review of pre-clinical data submitted by Wockhardt, which covered all essential information about the new molecule such as pharmacodynamics, pharmacokinetics, safety features and toxicology. Wockhardt has chosen KEM hospital, to conduct this trial. Wockhardt's Chairman, Habil Khorakiwala said, "The approval of our newly developed anti-infective, WCK-771 for Human Clinical trial by DCGI is indeed a significant development not only for Wockhardt but for the Indian pharmaceutical industry, and especially for India's scientific and research community. Our new proprietary anti-infective will be able to effectively treat some of the life- threatening and challenging infections such as sepsis and nosocomial (hospital-acquired) infections, This molecule has immense global potential. In fact, Wockhardt's New Drug Discovery programme has fructified to this level in a relatively short span of just four years. In addition to WCK-771, Wockhardt has several other lead molecules in the pipeline."

IFCI sells shares of Indo Rama Syn through negotiated deal with Promoters

IFCI Ltd has informed BSE that they have executed a negotiated deal on April 1, 2002 with Yield Securities & Credits Pvt Ltd for sale of 16,46,579 equity shares of Indorama Synthetics India Ltd (being 0.99% of the paid up capital) and with Virgin Securities & Credits Pvt Ltd for the sale of 16,46,580 equity shares of Indorama Synthetics India Ltd (being 0.99% of the paid up capital) at Rs 12.0445 per share, in terms of the share purchase agreement dated March 26, 2001 between IFCI & Shri OP Lohia, promoter of IRSL.

Neuland Lab receives Certificate of Suitability for its bulk drug from Council of Europe

Neuland Laboratories Ltd has informed BSE that the Company has received Certificate of Suitability for its bulk drug Ciprofloxacin Hydrochloride EP from Council of Europe. The product patent has already expired in Germany. Our Company is in an advanced stage of negotiations with three reputed European Companies for concluding long term contract for sale of this product at remunerative prices which will significantly improve the bottom line of the Company. Apart from our Company, only two other Companies, Bayer AG, Germany (original inventor of this product) and Quimica Sintetica, Spain have received COS for this product.

Herdillia Chemicals allots equity shares to Schenectady India Holdings

Herdillia Chemicals Ltd has informed BSE that at the meeting of the Committee of Directors held on March 31, 2002, the Company has allotted 1,20,00,000 Equity Shares (face value of Rs 10 each) at Rs 20 each aggregating Rs 240 million to its promoters, Schenectady India Holdings Ltd.

BOI returns Rs 1504.2 million Equity Capital to Central Govt

Bank of India has informed BSE that the Bank has returned Equity Capital to the tune of Rs 1504.20 million to the Central Government on March 30, 2002. Accordingly, the equity capital of the Bank stands reduced to Rs 4880 million and the equity shareholding of the Central Government in the Bank stands reduced to Rs 3385.80 million.

Steelco Gujarat Shareholders Grievance Committee allots equity shares to IDBI

Steelco Gujarat Ltd has informed BSE that ShareHolders Grievance Committee at its meeting held on March 30, 2002 has allotted 1,28,97,500 Equity Shares of Rs 10 each aggregating to Rs 12,89,75,000 to Industrial Development Bank of India in compliance of Order of BIFR dated September 6, 2001.

Bharat Earth Movers announces provisional results for the year 2001-02

Bharat Earth Movers Ltd has informed BSE the provisional results for the year 2001-02 subject to audit and approval by Board. The results are as under: - Sales (All time high) - Rs 14210 million Value of production - Rs 14700 million Profit before tax - Rs 125 million The year saw BEML consolidating its position in the Defence sector with contribution rising to 40%. Major orders were executed for supply of Tatra Trucks, Milrail Coaches Heavy/armoured recovery vehicles, personnel carriers, etc. During the year the third walking Dragline was delivered to Northern Coalfields Ltd. Two walking Draglines are under erection and delivery during the ensuing year. The sales included exports of Rs 1150 million of which physical exports was of the order of Rs 367 million covering Tunisia and Syria. The Company has comfortable Order Book position of about Rs 20,000 million for execution during the ensuing years. Major off-take is foreseen from the infrastructure sector in the coming years

ACC to publish FY-02 results by June 30, 2002

Associated Cement Companies Ltd has informed BSE that since the Company will be publishing the Audited Accounts for the financial year ended March 31, 2002 within the three months period (ie on or before June 30, 2002) the unaudited results for the quarter ended March 31, 2002 will not be published

Bank of Rajasthan denies news item

With reference to the news item appearing in a leading financial daily titled "Bank of Rajasthan in talks to acquire a bank in South" Bank of Rajasthan Ltd has informed BSE that the news article is totally baseless and hence the Bank denies the news article.

VisualSoft Tech enters into a partnership with Euclid Inc USA

VisualSoft Technologies Ltd has informed BSE that is has entered into a partnership with M/s Euclid Inc. USA a provider of next generation IT operational support system solutions, to provide application and infrastructure management services for Visualsoft clients worldwide. With Euclid's powerful Trinity Services Manager™ software and hosted services framework, Visualsoft clients have the foundation for optimized, scalable and cost efficient IT Operations. "The combined expertise of Euclid and VisualSoft will allow us to offer customers an ever more comprehensive solution," said Sateesh Andhra, co-founder and vice president of strategy and business development, Euclid. "VisulaSoft's strength in building application security products and providing systems integration services for Fortune 500 clients, strongly compliments Euclid's expertise in outsourced management of application and infrastructure for enterprises. In addition, Euclid will also be able to utilize VisualSoft's data center management and on-site/off-shore software development experience."

Sterlite acquires 26% Stake in Hindustan Zinc

The US$1.3 billion Sterlite Group (Sterlite) announces that it has been declared the successful bidder for the acquisition of a 26% equity stake in Hindustan Zinc Ltd for Rs 4450 million ($91.30 m) through Sterlite Opportunities and Ventures Ltd, a Special Purpose Vehicle set up for the same. The divestment represents a key step forward in the Indian privatisation programme and has received the necessary Government approvals. Sterlite will make an open offer for the further acquisition of 20% equity as per Securities & Exchange Board of India regulations. Under the terms of the acquisition, Sterlite will have management control of HZL. The acquisition is in line Sterlite's strategy to be a major player in the non-ferrous mining and metals business on a global basis. HZL will provide Sterlite with an entry into the zinc and lead market. This will complement Sterlite's existing aluminium and copper capabilities. The acquisition also fits in with the Group's overall strategy of growth through acquisitions building on the recent successful acquisitions of Bharat Aluminium Company Ltd in India together with Thalange and CMT copper mines in Australia. Sterlite is also currently expanding its copper smelter to 300,000 tonnes per year and aluminium to 400,000 tonnes per year on an integrated basis. Commenting on the acquisition Anil Agarwal Chairman of the Sterlite Group said " Sterlite is focussed on growing its core non-ferrous metals business to emerge as a leading international player. HZL expands our presence in this market and diversifies our portfolio to include zinc and lead as well as aluminium and copper. I believe that this broad product mix will benefit customers shareholders and employees.

Global Trust Bank strengthens its internal control system

Global Trust Bank Ltd has informed BSE that there has been a critical review by the Bank of its internal procedures, systems and particularly the advances portfolio. Over the past few months, the Bank has taken a number of measures to strengthen the internal control systems as well as setting up of a rigorous recovery machinery to critically examine and follow-up on problem accounts. These measures have yielded very good results and many of the major accounts have already been set right. The Bank is now all set to seize the opportunities and grow with strength. The reasons for some of these accounts becoming irregular were examined by the Board of Directors, in detail, to understand the deviations, lapses and to fix the responsibility. The findings have revealed certain deviations and serious irregularities in adhering to the laid down procedures as well as internal guidelines of the Bank. Based on these findings, the Board of Directors at the recent meeting has taken a decision to discharge some of the Bank's Senior Officers from the services of the Bank. All the above steps were taken in the process of clearing up the problems in the Bank. The Bank however continues to grow and has now 100 branches, 200 ATMs and recorded a growth of 25% in its customer base over the last one year. According to Sudhakar Gande, M D, the bank now has a platform for rapid growth, given the high calibre of their human resources, information technology infra-structure and the vastly revamped internal controls and procedures. It will be the Bank's endeavour to seize every growth opportunity and put the Bank on an accelerated growth path.

High court of Gujarat sanctions merger of Bulk Drug Unit of Darshak with Alembic

Alembic Ltd has informed BSE that the Board of Directors of the company has transacted the following business: 1. Noting of orders of High Court of Gujarat at Ahmedabad, sanctioning the merger of Bulk Drug Unit of M/s Darshak Ltd. with the company from April 1, 2000. 2. Issue of 1,44,946 equity shares of Rs 10 each credited as fully paid-up of the company to the shareholders of M/s Darshak Ltd. as per the scheme sanctioned by the Hon'ble High Court of Gujarat, but subject to the sanctioned of Hon'ble High Court of Karnataka

High Court directs Camphor & Allied Products to seek members approval for scheme of amalgamation

Camphor & Allied Products Ltd has informed BSE that the Hon'ble High Court at Ahmedabad has directed company to hold a General Meeting of shareholders on April 22, 2002 for getting their approval for scheme of amalgamation of Mulberry Investments & Trading Ltd with the company.

Ranbaxy, USA and Core Pharma LLC collaborative and exclusive venture receives FDA approval for Acetaminophen Extended-release tablets

Ranbaxy Pharmaceuticals Inc and Ohm Laboratories Inc., both wholly owned subsidiaries of Ranbaxy Laboratories Ltd, India in a collaborative and exclusive venture with Core Pharma LLC announced on Monday receiving the FDA approval for Acetaminophen Extended-release Tablets, 650mg. In this co-development and participative arrangement, CorePharma LLC of Middlesex, New Jersey, retains ownership for the ANDA and will manufacture the product, while Ohm Laboratories will have exclusive commercial rights to market this OTC product. RPI/Ohm's Acetaminophen Arthritis Tablets has an AB rating with proven bio-equivalence to Tylenol® Arthritis Pain Extended Relief Caplets. It is indicated for the temporary relief of minor aches and pains caused by arthritis, common cold, headaches, toothaches, muscular aches, backaches and menstrual cramps. The annual sales for Acetaminophen Arthritis Tablets is around $ 50 million. RPI/Ohm is the second generic manufacturer to be approved to market this product but the generic demand is largely unfulfilled because of manufacturing difficulties. Ohm Laboratories Inc. plans to launch this product in May 2002. This addition to Ohm's broad product portfolio enhances the Company's new product momentum in the growing OTC market which has a broad therapeutic representation in the analgesic, gastrointestinal and cough and cold categories.

Infosys Tech FY-02 results on April 10, 2002

A meeting of the board of directors of Infosys Technologies Ltd is scheduled to be held on April 10, 2002 to consider inter-alia the following items of business: 1. The audited financial results for the quarter ended March 31, 2002 and for the financial year ended March 31, 2002. 2. To recommended a Dividend for the year ended March 31, 2002 if any.

Gandhi Special Tubes Board decides not to proceed with buy back proposal

Gandhi Special Tubes Ltd has informed BSE that the board of directors of the company has decided not to proceed with the proposal of buy back of shares.

A P Singh ceases to be Director of Ganesh Polytex

Ganesh Polytex Ltd has informed BSE that the nomination of A P Singh has been withdrawn by PICUP from February 27, 2002 and he ceases to be director of the company from February 27, 2002.

Workmen's strike at FDC's Waluj plant

FDC Ltd has informed BSE that the settlement signed between the workmen at the Waluj Plant and the Management came to an end on August 31, 2001. After this date several rounds of negotiations have taken place for renewing the settlement for further period. In the meanwhile the workmen have gone on strike w e f April 01, 2002 though the matter has been admitted in conciliation with the Dy. Labour Commissioner at Aurangabad. Accordingly in the opinion of the Company the strike will be illegal. The management has taken adequate steps to ensure functioning of the plant.

Goldstone Teleservices Board approves allotment of 3 million equity warrants

Goldstone Teleservices Ltd has informed BSE that the board of directors of the company has decided to allot 3.00 million equity warrants to the following persons/entities: 1. M/s Goldstone Exports Ltd. - 20,00,000 equity warrants 2. L P Sashikumar - 2,25,000 equity warrants 3. J A Rao - 2,25,000 equity warrants 4. K Vasudeva Rao - 1,25,000 equity warrants 5. P Ramesh Babu - 1,25,000 equity warrants 6. Kishore V. Khandavalli - 1,25,000 equity warrants 7. G Bhagavat Reddy - 1,25,000 equity warrants 8. M Gopalkrishna - 50,000 equity warrants

IFCI opts for conversion of OFCDs of Welspun -Gujarat Stahl Rohren

Welspun -Gujarat Stahl Rohren Ltd has informed BSE that IFCI Ltd. have opted for conversion of Optionally FCDs Rs.18,63,60,000 out of OFCDs of Rs 333.4 million allotted to them into equity shares of Rs 10 each at par and balance stand converted into Redeemable Debentures. Accordingly, the equity Share Capital of the company increases from 12,27,19,760 equity shares of Rs 10 each to 14,13,55,760 equity shares of Rs 10 each.

IVP buy back to commence on April 2, 2002

BSE has informed the members of the exchange that IVP Limited has announced buyback of its fully paid-up equity shares of face value of Rs 10 each from the Open Market through electronic trading mechanism of the Exchange. The Maximum Buyback Price would not exceed Rs 22 per equity share payable in cash for an aggregate amount not exceeding Rs. 22.718 million. Proposed time table for buyback: Date of Opening of the Buyback on BOLT April 2, 2002 Last date for the Buyback September 20, 2002 or when the company has completed buyback to the extent of 10% of the paid-up equity capital under the offer or such earlier date as may be determined by the board. Details of Buyback orders on BOLT. The members may note that the Physical Equity Shares can be offered for Buyback to the company in the list of Non-Specified Securities under scrip code as mentioned below: Code No. : 532458 Market Lot : 1 Share Scrip ID on BOLT System : IVPPHBB Abbreviated Name on BOLT System : IVP LIMITED* The broker member buying the shares in physical mode under buyback will accept equity shares certificates of any denomination in buyback in respect of physical shares, since the market lot of the physical scrip shown on the BOLT is "one". Buyer Members can alter the price as well as quantity, as it is applicable in the normal trading.

Sica Breweries fixes record date for the purpose of scheme of amalgamation

BSE has informed the members of the exchange that Sica Breweries Ltd has fixed May 9, 2002 as the Record Date for the purpose of Scheme of Amalgamation of Sica Breweries Ltd., with Skol Breweries Ltd. As per the Scheme two equity share of Rs 10 each of Skol Breweries Ltd will be allotted for every one existing equity share of Rs 10 each of Sica Breweries Ltd, held. There will be no dealings in the aforesaid scrip with effect from April 19, 2002.

BSE revises special margin on 38 scrips

BSE has informed the members of the exchange that the following scrips will attract Special Margins as indicated hereunder with effect from Monday. The rates of special margins have been revised keeping in view the closing price of the scrip on the last day of the settlement. Special margins will be imposed on the basis of memberwise gross purchase or sales position (clientwise net) as indicated below: CODE NAME GROUP PER SHARE (PURCHASE)(%) 530707 AFTEK INFOSYS B1 25 532161 BAFFIN ENGINEER B2 25 532346 BLUE STAR B1 25 517544 C MAC CENTUM B1 25 500117 DCW B2 25 509028 E SERVE IN B1 25 526881 FINANCE TECH B2 25 532326 FORTUNE INFO B2 50 503699 GEODESIC INF B2 25 532312 GEOMETRIC SOFT B1 25 532439 GOLDSTONE TECH B2 25 532010 INDOTECH CAPITA B2 25 532175 INFOTECH ENTERP B1 50 511116 INVEST TRUST B1 25 531816 IT MICROSYSTEM B2 25 532283 KAASHYAP RADIA B2 25 500247 KOTAK MAHINDRA B1 25 532400 KPIT INFOSYSTEM B1 25 532337 MASCOT SYSTEM B1 25 526299 MPHASIS BFL B1 25 520021 OMAX AUTOS B1 25 531167 ORIENT INFOR B1 25 532350 PADMALAYA TELE B1 25 500327 PEACOCK INDUS B2 25 532165 RANSI SOFTWARE B2 25 511076 SAT INVESTMENT B2 50 512028 SHONKH TECHNOLO Z 25 530943 SRI ADHIKARI BR B1 25 532348 SUBEX SYSTEM B1 25 504290 TATA INFOTEC B1 25 532358 TELE DATA INF B2 25 532375 TIPS INDUSTRIES B1 25 531830 TODAY'S WRITING B2 25 500423 TVS ELECTRONICS B1 25 511110 V B DESAI B2 25 530769 VEL SOFTWARE B2 25 532214 VISUAL SOFTWARE B1 25 531404 ZICOM ELECTRONI B2 25

Cadila Healthcare to invest in Banyan Chemicals

Cadila Healthcare Ltd has informed BSE that the Board of Directors at its meeting held on Monday has decided to invest in all paid-up Equity Share Capital of M/s Banyan Chemicals Ltd. a closely held public Ltd Company and an U S FDA approved unit located in Vadodara District engaged in manufacturing of active pharmaceutical ingredients, intermediates and finished pharmaceuticals. The aggregate investment in terms of value for acquiring 100% shares will be around Rs 205.1 million.

Reasonable growth in operating profit in March quarter 2002 by HLL

Salient features by the Chairman on HLL's performance in MQ-2002. After a very good performance last year led by our strategy to focus on our Power Brands- we have had a slow start to this year. Sales in MQ 2002 will be below the corresponding period last year. This is due to both external and internal factors. We will however deliver a reasonable growth in our operating profit fort the quarter On the external front the markets continue to be sluggish with several of our categories-notably PW, Laundry, Tea-continuing to show degrowth. This has also led the retail trade to bring down stock investments to reflect this. Coming now to our own operations- we are taking several initiatives, which are resulting in a lower topline in the immediate term. Firstly we are determined to improve the profitability of our foods business just as we did for our beverages business last year. Consequently we are improving gross margins by focussing on our more profitable SKUs, stopping unprofitable ones etc. We are also simultaneously investing in value added innovations. Secondly we are moving to a new HLL WAY IN SALES. We will now focus our salesforce only on driving secondary sales- sales from our stockists to the retail trade. We are using IT to connect all our stockists to our supply chain so we can run a replenishment-based system. This rollout has led to a planned decrease in our stockists inventories with an adverse impact on the short-term topline. However this will lead to a much more responsive and efficient supply chain. Thirdly, we have discontinued traded exports in this quarter, which will also effect our topline. Traded exports do not add anything to our bottomline- they only consume management resources Finally our innovation plan in MQ this year is relatively light compared with the rest of the year. Consequently our A&P spend as well as our sales phasing is backweighted into the year.

Hero Honda FY-02 motorcycles sales up by 38.44%

Hero Honda Motors Ltd has informed BSE that the company has sold 14,25,302 nos of motorcycles during the financial year ended 2001-2002 as compared to 10,29,510 nos of motorcycles during the financial year.

Gillette India post a net loss of Rs 277.90 million in FY-01 due to extra-ordinary items

Gillette India Ltd has posted a net loss of Rs 277.90 million for the financial year ended December 31, 2001 as compared to a net profit of Rs 264.20 million in the financial year ended December 31, 2000. Total Income has decreased from Rs 5365.40 million in FY-00 to Rs 5116.80 million in the year ended December 31, 2001. The company has incurred Rs 606.40 million as extraordinary items during the year ended December 31, 2001. Based on the recommendations of the review & implementation committee, The Board of Directors has approved sale of plant & equipment of Duracell Manesar plant.